ACT webinar on Animal Models of Disease for Nonclincial Safety Assessment

Event Date: December 6th 11:12 - 6th 12:12 2017


ACT sponsors quarterly webinars on current topics in toxicology, including primarily drug and chemical safety assessments. Presenters are experts in their field, with backgrounds in government, industry or academia. The goal of the webinar series is to provide accessible education on topics in toxicology to ACT members and, more broadly, members of the toxicology community worldwide. ACT Webinars are reaching thousands, with collaborations spanning the globe while increasing individual and corporate ACT membership and participation.

Hosted by the American College of Toxicology and the Society of Toxicologic Pathology
in Collaboration with the British Toxicology Society and the Teratology Society

Webinar Abstract:
Considerations for the use of animal models of disease will be discussed with specific examples of organ systems and/or responses that are generally either well or poorly predicted with the use of conventional animal models. The results of a recent survey (IQ Focus Group) that queried the current practices as it pertains to the use of animal models in nonclinical safety assessment will be presented. Attention will be given to differentiating the use of animal models of disease in discovery vs. development as well as describing common themes across industry.

Sherry J. Morgan, DVM, PhD, ACVP, ABT, ABVT, AbbVie

Registration is required.